v3.25.4
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Dec. 31, 2025
Sep. 30, 2025
Sep. 30, 2024
Current Assets:      
Cash and cash equivalents $ 7,295,451 $ 3,924,908 $ 112
Accounts receivable, net of allowances 4,049,111  
Inventory 22,639,342 22,286,693 8,268,766
Prepaid expenses 3,162,940 1,331,280 2,700,000
Total Current Assets 37,146,844 27,542,881 10,968,878
Other Assets:      
In-process research and development, net of accumulated amortization 72,826,562 73,400,000 73,400,000
Total Other Assets 72,826,562 73,400,000 73,400,000
Total Assets 109,973,406 100,942,881 84,368,878
Current Liabilities:      
Accounts payable 10,446,900 13,234,684 3,711,622
License payable 18,250,000 22,650,000 28,400,000
Accrued expenses 4,518,916 4,093,124
Total Current Liabilities 44,710,394 49,491,579 32,700,429
Deferred tax liability 3,049,200 2,784,960 1,728,000
Total Liabilities 51,559,705 56,076,650 38,228,540
Stockholders’ Equity:      
Preferred stock - $0.0001 par value; 10,000,000 shares authorized: no shares issued and outstanding
Common stock, value 8,480 8,351 7,155
Additional paid-in capital 127,979,246 108,897,836 85,411,771
Accumulated deficit (69,574,025) (64,039,956) (39,278,587)
Total Stockholders’ Equity 58,413,701 44,866,231 46,140,339
Total Liabilities and Stockholders’ Equity 109,973,406 100,942,881 84,368,878
Related Party      
Current Liabilities:      
Due to related party 11,494,578 9,513,771 588,806
Note payable to related party $ 3,800,111 $ 3,800,111 $ 3,800,111